Medical expulsive therapy for distal ureteric stones: Tamsulosin versus silodosin

Archivio Italiano di Urologia e Andrologia

Volumn 86, Issue 2, 2014, Pages 103-107

  Imperatore, Vittorio ^a   Fusco, Ferdinando ^b   Creta, Massimiliano ^a   Di Meo, Sergio ^a   Buonopane, Roberto ^a   Longo, Nicola ^b   Imbimbo, Ciro ^b   Mirone, Vincenzo ^b  

^a Ospedale Buonconsiglio Fatebenefratelli   (Italy)

^b FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Medical expulsive therapy; Silodosin; Stones; Tamsulosin

Indexed keywords

ANALGESIC AGENT; DICLOFENAC; SILODOSIN; TAMSULOSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISTAL URETERIC STONE; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ECHOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; MEDICAL EXPULSIVE THERAPY; MINIMALLY INVASIVE PROCEDURE; NOSE OBSTRUCTION; OBSERVATIONAL STUDY; ORTHOSTATIC HYPOTENSION; PAIN; RETROGRADE EJACULATION; RETROSPECTIVE STUDY; SACROILIAC JOINT; SINGLE DRUG DOSE; URETER STONE; URETEROSCOPY; UROLOGICAL PROCEDURE; VASODILATATION;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; AGED; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SULFONAMIDES; URETERAL CALCULI;

EID: 84906683227     PISSN: 11243562     EISSN: 22824197     Source Type: Journal    
DOI: 10.4081/aiua.2014.2.103     Document Type: Article

References (29)

1. Ahmed AF, Al-Sayed AY. Tamsulosin versus Alfuzosin in the Treatment of Patients with Distal Ureteral Stones:Prospective, Randomized, Comparative Study. Korean J Urol. 2010; 51:193-7.
2. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medicalexpulsive therapy for distal ureteral calculi. J Urol. 2005; 174:167-72.
3. Malin JM Jr, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter.Br J Urol. 1970; 42:171-4.
4. Küpeli B, Irkilata L, Gürocak S, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wavelithotripsy? Urology. 2004; 64:1111-5.
5. Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005; 173:2010-2.
6. Itoh Y, Kojima Y, Yasui T, et al. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol. 2007; 14:749-53.
7. Sasaki S, Tomiyama Y, Kobayashi S, et al. Characterization of á1-adrenoceptor subtypes mediating contraction in human isolated ureters. Urology. 2011; 77:762.e13-7.
8. De Sio M, Autorino R, Di Lorenzo G, et al. Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J Endourol. 2006; 20:12-6.
9. Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med 2007; 50:552-63.
10. Parsons JK, Hergan LA, Sakamoto K, Lakin C. Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol. 2007; 177:983-7
11. Hollingsworth JM, Rogers MA, Kaufman SR, et al, Hollenbeck Medical therapy to facilitate urinary stone passage: a meta-analysis. .Lancet. 2006; 368:1171-9.
12. Watts HF, Tekwani KL, Chan CW, et al. The effect of alphablockade in emergency department patients with ureterolithiasis. J Emerg Med. 2010; 38:368-73.
13. Türk C, Knoll T, Petrik A, et al. Guidelines on Urolithiasis European Association of Urology Updated March 2011.
14. Kobayashi S, Tomiyama Y, Hoyano Y, et al. Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouseureter. World J Urol. 2009; 27:775-80.
15. Itoh Y, Okada A, Yasui T, et al. Efficacy of selective α1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones. Int J Urol. 2011; 18:672-4.
16. Tsuzaka Y, Matsushima H, Kaneko T, et al. Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients. Int J Urol. 2011; 18:792-5.
17. Tzortzis V, Mamoulakis C, Rioja J, et al. Medical expulsive therapy for distal ureteral stones. Drugs. 2009; 69:677-92.
18. Griwan MS, Singh SK, Paul H, et al. The efficacy of tamsulosin in lower ureteral calculi. Urol Ann. 2010; 2:63-6.
19. Al-Ansari A, Al-Naimi A, Alobaidy A, et al. Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients. Urology. 2010; 75:4-7.
20. Abdel-Meguid TA, Tayib A, Al-Sayyad A. Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial. Can J Urol. 2010; 17:5178-83.
21. Agrawal M, Gupta M, Gupta A, et al. Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin inmanagement of lower ureteral stones. Urology. 2009; 73:706-9.
22. Chapple CR. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. Rev Urol. 2005; 7 Suppl 4:S22-30.
23. Montorsi F. Profile of Silodosin Eur Urol Suppl. 2010; 491-495
24. Chapple CR, Montorsi F, Tammela TL, et al. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, doubleblind, placebo- andactive-controlled clinical trial performed in Europe. Eur Urol. 2011; 59:342-52.
25. Yoshida M, Kudoh J, Homma Y, et al. Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia. Clin Interv Aging. 2011; 6:161-72.
26. Rossi M, Roumeguère T. Silodosin in the treatment of benign prostatic hyperplasia. Drug Des Devel Ther. 2010; 27; 4:291-7.
27. Yu HJ, Lin AT, Yang SS, et al. Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). BJU Int. 2011; 108:1843-8.
28. Schilit S, Benzeroual KE. Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia. Clin Ther. 2009; 31:2489-502.
29. Marks LS, Gittelman MC, Hill LA, et al. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol. 2009; 181:2634-40